Biotech Co. Must Face Investor Suit Over Misleading Claims

By Sydney Price · June 26, 2025, 7:47 PM EDT

Biotech company CytoDyn and its former executives and directors cannot escape a suit accusing them of misleading shareholders about the likelihood that the U.S. Food and Drug Administration would approve its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Courter et al v. CytoDyn Inc et al

Case Number

3:21-cv-05190

Court

Washington Western

Nature of Suit

Securities/Commodities

Date Filed

March 17, 2021